Remove Investors Remove Medical Remove Private Equity
article thumbnail

Manufacturing’s moment: Why private equity is doubling down

Private Equity Info

With ongoing demand for specialty drugs, biologics, and generics, private equity sees long-term value in platforms that can scale and innovate within FDA-compliant environments. Medical Equipment and Supplies Manufacturing From surgical instruments to diagnostic devices, this sector is central to modern healthcare delivery.

article thumbnail

2025 Dental Transactions Update

Focus Investment Banking

2025 Dental Transactions Update As of June 2025, our research shows approximately 130 private equity backed DSOs operating across the dental services landscape – more than in any other healthcare vertical. DSO Creation Private equity investment in dental practices began in the 1990’s when the first DSOs sought outside investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Private Equity uses ‘Roll-up’ Strategies to Drive Investment Returns

OfficeHours

In the pursuit of attractive equity returns, private equity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of private equity-backed roll-up activity.

article thumbnail

[Video] Podcast - Counsel That Cares - Increased Investor Interest in Cardiology

JD Supra: Mergers

In this episode of “Counsel That Cares,” healthcare and private equity attorney David G. By: Holland & Knight LLP

article thumbnail

The Full Guide to Healthcare Private Equity, from Careers to Contradictions

Mergers and Inquisitions

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?

article thumbnail

ENT & Allergy Practices Attract Private Equity

Focus Investment Banking

Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. ENT and allergy is relatively new to private equity investment, with approximately ten major platforms currently operating.

article thumbnail

Private Equity Interest in Orthopedics Grows

Focus Investment Banking

Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.